39 results
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
, especially in the current litigious environment and regardless of merit. Limiting concern about personal risk would empower both directors and officers … to devote to his position in the current business environment, as well as the commitment required to serve as our chairman, particularly as the board
8-K
EX-1.1
AKRO
Akero Therapeutics Inc
6 Mar 24
Entry into a Material Definitive Agreement
5:25pm
enforceable requirements relating to pollution or the protection of human health or safety, the environment, natural resources, hazardous or toxic substances … , injecting, escaping, leaching, dumping, disposing, depositing, dispersing, or migrating in, into or through the environment, or in, into from
8-K
EX-1.1
0tb5va0hy gmmrbzpo
17 May 23
Akero Therapeutics Announces Pricing of $220.0 Million Underwritten Offering of Common Stock
5:01pm
8-K
EX-1.1
8o8m2ljqr ihd
16 Sep 22
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.1
kq5o8a8
16 Jun 22
Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million
7:14am
S-3ASR
EX-1.2
5umweph34
18 May 21
Automatic shelf registration
6:01am